(PharmaNewsWire.Com, September 27, 2017 ) The North America Cell Based Assay Market was worth USD 3.78 billion in 2016 and estimated to be growing at a CAGR of 10.63%, to reach USD 6.26 billion by 2021. North America accounted for the largest share in the global cell-based assays market in 2016.
Cell based assays Market helps in measuring cell proliferations, motility, toxicity, production of a measurable product and morphology in diagnostics and drug discovery. Cell based assays also facilitate research in the area of stem cells, cancer, immunology and others. The major market propellants for cell-based assays are benefits of cell-based assays over biochemical assays and animal models and public-private partnerships for drug discovery.
The key driver for this market is increased R&D spending on research. Furthermore, growing benefits of cell-based assays over other methods, their increasing adoption in drug discovery, and advancements in automation and high-throughput techniques will aid market growth. Increased research and development spending by pharmaceutical and biotechnology companies aided by increasing drug development research, which has a strong upward trend worldwide and is expected to drive the cell-based assays market. High cost of procedure is restraining the market growth.
The North America cell based assay market is segmented on the basis of type of product into Cell Lines, Assay Ready Kits, Cell Culture Kits, Reagents & Consumables and Ligands & Inhibitors. Cell Lines segment is further divided into Primary Cell Lines, Stem Cell Lines and Immortalized Cell Lines. On the basis of technology, market is segregated into Automated Handling, Flow Cytometry, Label-Free Detection, High Content Screening and High Throughput Screening. Based on application market is bifurcated among Drug Discovery and ADME Research. By End User type, segmentation is among Academia, Biotechnology, Pharmaceuticals and CRO.
Based on geography the market is analysed under various countries namely, USA and Canada. USA is leading the cell based assay market followed by Canada.
The top leaders in cell-based assays market include Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck & Co. Inc., Cell Signalling Technology Inc., PerkinElmer Inc., Danaher Corporation, General Electric Company, Cisbio Bioassays, DiscoveRx, Ametek Inc., Bio-Rad Laboratories, Roche Diagnostics, GE Healthcare and Promega Corporation.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
